Clinical trial · Interventional
Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP)
A Prospective Multi-center Randomized Clinical Trial to Compare Survival Rates and Quality of Life According to Follow-up Period in Patients Who Underwent Radical Gastrectomy for Advanced Gastric Cancer (STOFOLUP Trial)
NCT04740346CI-TRIAL-00054694unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is a multi-center, prospective, randomized controlled study. The aim of this study is to compare survival rates and to observe quality of life and nutritional status according to follow-up period in patients who underwent radical gastrectomy for stage 2 or 3 gastric cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| Quality of Life | — | UNRESOLVED | — |
| Recurrence | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Computed tomography, Chest X-ray, and blood test | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- 3 months follow-up
- description
- Patients will be follow-up every 3 months after gastrectomy.
- interventionNames
- Diagnostic Test: Computed tomography, Chest X-ray, and blood test
- type
- ACTIVE_COMPARATOR
- label
- 6 months follow-up
- description
- Patients will be follow-up every 6 months after gastrectomy.
- interventionNames
- Diagnostic Test: Computed tomography, Chest X-ray, and blood test
Primary outcomes (1)
- measure
- 3-year overall survival
- timeFrame
- 3 years after surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * Patients aged 19 years or more * Patients who are diagnosed with pathological stage II or III gastric adenocarcinoma according to the AJCC 8th edition * Patients who can understand all information about the trial and decide for themselves whether to participate in this study Exclusion Criteria: * Vulnerable patients such as pregnant and intellectual disability * Patients who cannot undergo CT owing to poor kidney function or severe adverse effects * Patients who are already in another study and cannot follow the schedule for this trial * Patients who are diagnosed with a cancer other than gastric cancer within five years before the gastrectomy * Patients being treated for a cancer other than gastric cancer
References
Publications (1)
- DERIVEDEom BW, Koo DH, An JY, Lee HH, Kim HI, Hur H, Yoo MW, Ryu MH, Lee HJ, Kim SM, Park JH, Min JS, Seo KW, Jeong SH, Jeong O, Kwon OK, Ryu SW, Yoo CH, Bae JM, Ryu KW. Prospective multicentre randomised clinical trial comparing survival rates, quality of life and nutritional status between advanced gastric cancer patients with different follow-up intensities: study protocol for the STOFOLUP trial. BMJ Open. 2021 Dec 8;11(12):e056187. doi: 10.1136/bmjopen-2021-056187. PMID 34880028